Your browser doesn't support javascript.
loading
Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.
Jeng, Bennie H; Hamrah, Pedram; Kirshner, Ziv Z; Mendez, Benjamin C; Wessel, Howard C; Brown, Larry R; Steed, David L.
Affiliation
  • Jeng BH; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hamrah P; Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Kirshner ZZ; Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, USA.
  • Mendez BC; Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, USA.
  • Wessel HC; Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, USA.
  • Brown LR; Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, USA.
  • Steed DL; Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, USA.
Transl Vis Sci Technol ; 11(1): 8, 2022 01 03.
Article in En | MEDLINE | ID: mdl-34994777
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Corneal Diseases / Secretome Type of study: Clinical_trials Limits: Humans Language: En Journal: Transl Vis Sci Technol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Corneal Diseases / Secretome Type of study: Clinical_trials Limits: Humans Language: En Journal: Transl Vis Sci Technol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States